LEVOSIMENDAN
Positive inotropic agent with vasodilating activity
Specification – pharmacopeia: In House
Therapeutic category: cardiotonic
Treatment: Adjuvant for treatment of chronic cardiac insufficiency and cardiac insufficiency post-stroke.
Pharmacology: Levosimendan increases the sensibility of cardiac contractile proteins for Ca2+ ions, through Cardiac Troponin C (cTnC) binding, increasing the contractile force and opens the ATP sensitive canal in the vascular smooth muscle, allowing the vase-dilatation inside arteries.
Aplicación: human
CAS number: 141505-33-1
Chemical formula: C14H12N6O
sales@interquim.com.mx